根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-20-002375 Act: 34 Size: 3 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-20-002309 Act: 34 Size: 966 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-001806 Size: 15 KB 网页链接
$Isoray(ISR)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000238 Act: 33 Size: 1 KB 网页链接
$Isoray(ISR)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001437749-20-001024 Act: 33 Size: 80 KB 网页链接
$Isoray(ISR)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001437749-20-001027 Act: 33 Size: 306 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-20-000733 Act: 34 Size: 123 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001437749-19-024532 Act: 34 Size: 45 KB 网页链接
$Isoray(ISR)$ 8-K Current report, item 5.07 Accession Number: 0001437749-19-024428 Act: 34 Size: 44 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-19-024113 Act: 34 Size: 3 MB 网页链接